age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66.26099
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 9
| 26,964
| 16,679.6406
| 17,071
| 16.5
|
black
| 26.796875
| 51
| 0.689941
| 0.5979
| 4
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 9
| 102
| 6.799805
| 60
| 16
| 38
| null | null | 0.599976
| 1.299805
| 140
| null | 91
| 15
| null | 0
| 6
| null | 6
| 252
| 1
|
68.88196
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 7
|
under $11k
| 9
| 21,663
| 13,114.1641
| 13,237
| 18.5
|
white
| 18.597656
| 37
| 0.843994
| 0.744995
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 10
| 112
| 5.599609
| 80
| 10
| 36.89844
| 292
| 1.399902
| 1.199951
| 0.599976
| 138
| 7.429688
| 104
| 13
| 1,450
| null | 0
|
no(M2 and SIP pres)
| 0
| 334
| 1
|
73.79297
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 10,375
| 6,902.6602
| 7,978
| 11.5
|
white
| 22
| 23
| 0.569946
| 0.248993
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.1
|
dnr after sadm
| 4
| 77
| 7.899414
| 95
| 26
| 38.39844
| 78
| 3.399902
| 0.699951
| 1.099854
| 138
| 7.069336
| 130
| 28
| 1,175
| 7
| 3
|
<2 mo. follow-up
| 3
| 16
| 1
|
52.76898
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 121,661
| null | null | 23
|
black
| 29.296875
| 77
| 0.68396
| 0.589966
| 41
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 55
| 154
| 27.398438
| 150
| 36
| 35.79688
| 168.3125
| 2.599609
| 6.799805
| 1.799805
| 146
| 7.319336
| 210
| 60
| 4,670
| 0
| null |
adl>=4 (>=5 if sur)
| 0.494751
| 193
| 1
|
91.16797
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null |
$11-$25k
| 9
| 7,025
| 4,443.6758
| 6,459
| 8
|
white
| 24
| 44
| 0.567993
| 0.372986
| 1
| 0
| 0
|
no
| null | null |
dnr before sadm
| -1
| 133
| 6.899414
| 135
| 6
| 35.89844
| 300
| null | 0.399963
| 1.199951
| 142
| 7.329102
| 133
| 10
| 1,120
| null | null |
adl>=4 (>=5 if sur)
| 5.06543
| 543
| 0
|
53.26199
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,797
| 2,928.8633
| 2,974
| 6
|
white
| 15
| 13
| 0.769897
| 0.522949
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 4
| 135
| 10
| 55
| 24
| 35.69531
| 203.3125
| null | 0.699951
| 1.199951
| 150
| 7.469727
| 145
| 11
| 2,749
| null | null |
<2 mo. follow-up
| 1.969238
| 16
| 1
|
59.73999
|
female
| 1
| 30
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 90,045
| null | null | 28.5
|
white
| 42.195313
| 60
| 0.44696
| 0.244995
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 30
| 60
| 9.798828
| 100
| 8
| 36.19531
| 348.5625
| null | null | 0.699951
| 141
| 7.369141
| 162
| 7
| 1,900
| null | 0
|
<2 mo. follow-up
| 0
| 30
| 1
|
82.56
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 2
|
under $11k
| 0
| 31,745
| 18,582.2031
| 20,927
| 11.5
|
white
| 15.398438
| 17
| 0.859985
| 0.768921
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 53
| 128.78125
| 150
| 24
| 38.69531
| 242.5
| 2.5
| 2.299805
| 2.399902
| 142
| 7.30957
| 109
| 44
| 260
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 541
| 0
|
54.237
|
male
| 1
| 5
|
Coma
|
Coma
| 0
| 7
| null | 0
| 36,353
| null | null | 45
|
other
| 37.898438
| 78
| 0.424988
| 0.350952
| 1
| 0
| 0
|
no
| 0.5
| 0.35
|
dnr after sadm
| 5
| 103
| 7.299805
| 60
| 24
| 36.09375
| 185
| 2.5
| 1.599854
| 0.799927
| 134
| 7.359375
| 240
| 8
| 2,080
| null | 1
|
<2 mo. follow-up
| 1
| 5
| 1
|
65.60699
|
male
| 1
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 14,532
| null | null | 31
|
hispanic
| 65.390625
| 100
| 0
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 63
| 6.599609
| 70
| 16
| 36.69531
| null | 3.599609
| 0.5
| 1.799805
| 135
| null | 73
| 40
| 1,200
| null | null |
<2 mo. follow-up
| 1.799561
| 4
| 1
|
69.224
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 10,246
| 6,972.5977
| 7,689
| 10
|
white
| 17.199219
| 5
| 0.69397
| 0.403992
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 9
| 53
| 7.5
| 68
| 48
| 36.59375
| 168
| null | 0.5
| 0.699951
| 137
| 7.369141
| 85
| 13
| 2,650
| null | 0
|
Coma or Intub
| 0
| 104
| 1
|
65.28998
|
female
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 44
| 198,680
| 116,222.125
| 113,054
| 34.75
|
white
| 25.199219
| 35
| 0.559937
| 0.44696
| 8
| 0
| 0
|
no
| 0.7
| 0.8
|
no dnr
| 46
| 27
| 18.199219
| 180
| 22
| 38.19531
| 243.3125
| null | null | 1.599854
| 142
| 7.30957
| 211
| 26
| 0
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 538
| 0
|
73.32196
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 24,700
| null | null | 18
|
white
| 18.898438
| 18
| 0.848999
| 0.751953
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 9
| 113
| 6.299805
| 60
| 9
| 38.39844
| 259
| null | null | 1.399902
| 133
| 7.489258
| 102
| 20
| 2,030
| null | null |
<2 mo. follow-up
| 2.810059
| 42
| 1
|
80.39996
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 27,456
| null | null | 26.5
|
white
| 23.398438
| 32
| 0.720947
| 0.565918
| 1
| 0
| 0
|
no
| 0.85
| 0.65
|
no dnr
| 10
| 43
| 45.898438
| 135
| 22
| 38.69531
| 125.45312
| null | 5.199219
| 11.298828
| 136
| 7.339844
| 142
| 111
| 15
| null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
47.97498
|
male
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
| null | 0
| 89,130
| 57,088.8438
| 59,258
| 21.25
|
white
| 16.597656
| 12
| 0.904907
| 0.870972
| 4
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 43
| 105
| 15
| 105
| 30
| 34.19531
| 297.125
| 3.399902
| 1
| 5.799805
| 140
| 7.279297
| 145
| 53
| 810
| null | 0
|
no(M2 and SIP pres)
| 0
| 536
| 0
|
57.02899
|
male
| 0
| 17
|
Lung Cancer
|
Cancer
| 1
| 0
|
under $11k
| 0
| 16,234
| 10,966.8984
| 12,575
| 5.666664
|
white
| 26.699219
| 22
| 0.494995
| 0.174988
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
no dnr
| 17
| 120
| 3
| 115
| 10
| 38.5
| 167.5
| 3.299805
| 2.599609
| 0.899902
| 146
| 7.30957
| 89
| 19
| 2,110
| null | 1
|
<2 mo. follow-up
| 1
| 48
| 1
|
71.59998
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 0
| 8,299
| 6,645.6406
| 6,728
| 10.5
|
black
| 15.699219
| 10
| 0.884888
| 0.80896
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 7
| 62
| 8.798828
| 75
| 28
| 35.29688
| 172.5
| null | null | 1.199951
| 140
| 7.449219
| 123
| 35
| 1,165
| null | 1
| null | 1
| 130
| 1
|
59.39798
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 38,214
| 23,649.0312
| 24,873
| 24.333328
|
white
| 22
| 25
| 0.812988
| 0.75
| 1
| 0
| 0
|
yes
| 0.75
| 0.65
|
no dnr
| 20
| 62
| 13
| 125
| 36
| 39.09375
| 343.3125
| null | 0.5
| 4.699219
| 138
| 7.419922
| 546
| 43
| 1,012
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 536
| 0
|
85.25397
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 5,269
| 3,610.668
| 3,689
| 7
|
white
| 19.597656
| 16
| 0.797974
| 0.67395
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 4
| 145
| 6.599609
| 60
| 8
| 37.89844
| 283.3125
| 3.099609
| 0.399963
| 1.099854
| 141
| 7.299805
| 258
| 27
| 2,147
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 535
| 0
|
66.89398
|
male
| 0
| 35
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$11-$25k
| 41
| 42,993
| 29,988.3438
| 34,828
| 17.25
|
white
| 29
| 49
| 0.55896
| 0.362976
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 5
| 18
| 9.898438
| 35
| 36
| 38.19531
| 195
| null | null | 2.099609
| 137
| 7.449219
| 413
| 52
| 1,065
| null | 0
|
no(M2 and SIP pres)
| 0
| 534
| 0
|
72.74194
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 0
| 79,139
| 45,057.0312
| 43,214
| 39.333313
|
white
| 32.796875
| 77
| 0.600952
| 0.493958
| 1
| 0
| 0
|
no
| 0.35
| 0.3
|
dnr after sadm
| 11
| 52
| 0.099991
| 135
| 26
| 36.09375
| 316.625
| 2.599609
| 10.5
| 2.899902
| 143
| 7.299805
| 86
| 90
| 435
| null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
63.92599
|
male
| 1
| 16
|
Coma
|
Coma
| 1
| 10
|
under $11k
| 55
| 45,913
| 27,442.4531
| 29,277
| 22.666656
|
white
| 17.5
| 31
| 0.547974
| 0.478943
| 1
| 0
| 0
|
yes
| 0.1
| 0.02
|
dnr after sadm
| 4
| 108
| 18.597656
| 120
| 20
| 35.79688
| 660
| null | null | 0.699951
| 136
| 7.449219
| 156
| 15
| 700
| null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
44.85699
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 100
| 51,906
| 29,462.7344
| 30,650
| 16
|
black
| 28.898438
| 37
| 0.534912
| 0.335999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 68
| 8.398438
| 105
| 8
| 35.29688
| 250
| 2.699707
| 0.399963
| 0.599976
| 142
| 7.429688
| 106
| 8
| 5,065
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 135
| 1
|
66.54596
|
female
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 44
| 147,889
| null | null | 44.25
|
white
| 42
| 77
| 0.102997
| 0.042999
| 1
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 24
| 115
| null | 75
| 12
| 36.19531
| 433.3125
| null | null | 1.199951
| 145
| 7.40918
| 178
| 16
| 1,725
| null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
30.10799
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| null | null | null | 14
|
white
| 22.296875
| 31
| 0.897949
| 0.860962
| 3
| 0
| 0
|
no
| 0.8
| 0.6
| null | null | 30
| 1
| 175
| 35
| 39.09375
| 131.65625
| 3.099609
| 0.299988
| 1.899902
| 153
| 7.149414
| 9
| 52
| 843
| null | 0
|
no(M2 and SIP pres)
| 0
| 532
| 0
|
64.12
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 39,588
| 23,305.7969
| 26,626
| 23.333328
|
black
| 37.195313
| 50
| 0.494995
| 0.376953
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 14
| 108
| 12.199219
| 65
| 24
| 38.09375
| 268.5625
| null | 0.799927
| 8.199219
| 129
| 7.439453
| 225
| 39
| 0
| null | 0
|
SIP>=30
| 0
| 531
| 0
|
65.81799
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 7,743
| 5,370.8398
| 6,120
| 6.5
|
white
| 16.898438
| 1
| 0.889893
| 0.816895
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 7
| 128
| 10.798828
| 55
| 8
| 39.09375
| 270
| null | 0.699951
| 1.299805
| 160
| 7.449219
| 153
| 17
| 1,975
| 0
| null |
SIP>=30
| 0.494751
| 397
| 1
|
69.10297
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
| null | 0
| 13,926
| 8,603.0234
| 9,492
| 17
|
white
| 16.296875
| 23
| 0.885986
| 0.809937
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 6
| 48
| 12.199219
| 125
| 26
| 36.19531
| 869.375
| null | null | 2.899902
| 158
| 7.30957
| 272
| 79
| 925
| null | null |
no(M2 and SIP pres)
| 2.119141
| 533
| 0
|
74.58997
|
male
| 1
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 8,683
| 5,717.5
| 6,143
| 12.5
|
white
| 20.699219
| 19
| 0.806885
| 0.688965
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 5
| 112
| 33
| 115
| 38
| 38.09375
| 251.40625
| 2.399902
| 24.398438
| 2
| 145
| 7.459961
| 379
| 121
| 2,330
| 1
| 2
|
<2 mo. follow-up
| 2
| 8
| 1
|
56.939
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 54,366
| 35,763.0938
| 39,123
| 19
|
black
| 26.796875
| 43
| 0.718994
| 0.631958
| 26
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 12
| 75
| 6.399414
| 95
| 30
| 38
| 348
| 2
| 1.5
| 0.899902
| 147
| 7.489258
| 138
| 22
| 1,010
| null | 3
|
no(M2 and SIP pres)
| 3
| 532
| 0
|
66.02594
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
| null | 0
| 44,230
| 22,836.0156
| 23,455
| 57
|
white
| 40.296875
| 64
| 0.439941
| 0.319946
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 148
| 12.798828
| 105
| 26
| 36.59375
| 232.5
| null | null | 0.699951
| 148
| 7.429688
| 298
| 14
| 2,875
| null | null |
<2 mo. follow-up
| 1.963135
| 4
| 1
|
41.09
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 6,703
| 4,328.6406
| 5,094
| 4
|
black
| 23.699219
| 12
| 0.625
| 0.311951
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 75
| 6.099609
| 70
| 16
| 36.29688
| null | 4.099609
| 0.399963
| 0.799927
| 144
| null | 112
| 6
| 7,250
| 0
| null |
<2 mo. follow-up
| 0.494751
| 23
| 1
|
75.95898
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 43,724
| 26,366.875
| 26,451
| 24.333328
|
white
| 33.195313
| 38
| 0.324951
| 0.210999
| 5
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 14
| 95
| 6.199219
| 70
| 18
| 36.09375
| 323.75
| null | 2.799805
| 1.199951
| 135
| 7.439453
| 68
| 15
| 1,925
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 241
| 1
|
52.45999
|
female
| 1
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 41
| 119,149
| 67,033.5
| 64,675
| 43
|
white
| 40.398438
| 73
| 0.081985
| 0.012999
| 21
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 8
| 68
| 13.099609
| 105
| 32
| 36.69531
| 357.125
| 3
| 0.399963
| 0.899902
| 137
| 7.379883
| 105
| 15
| null | null | 2
|
<2 mo. follow-up
| 2
| 9
| 1
|
49.71698
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 41
| 70,066
| null | null | 53.5
|
white
| 35.195313
| 59
| 0.44397
| 0.324951
| 3
| 0
| 0
|
no
| 0.05
| 0
|
dnr after sadm
| 4
| 138
| 15.298828
| 125
| 20
| 38
| 242
| 2.099609
| 1.199951
| 0.599976
| 132
| 7.279297
| 153
| 12
| 1,915
| null | null |
<2 mo. follow-up
| 2.615723
| 13
| 1
|
39.32098
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 0
| 36,544
| 23,668.5156
| 25,044
| 19
|
black
| 17.597656
| 24
| 0.919922
| 0.889893
| 2
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 15
| 53
| 22.898438
| 130
| 24
| 39.19531
| 132
| null | null | 1
| 135
| 7.419922
| 99
| 14
| 1,665
| null | 5
| null | 5
| 529
| 0
|
67.51495
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 98,266
| null | null | 52
|
white
| 47.796875
| 127
| 0.028999
| 0.007
| 20
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 5
| 97
| 17
| 68
| 20
| 36
| null | 4
| 0.799927
| 0.699951
| 142
| null | 125
| 13
| null | null | null |
<2 mo. follow-up
| 1.925293
| 5
| 1
|
61.80698
|
male
| 1
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 9
| 44,938
| 24,608.9219
| 26,028
| 28
|
white
| 35.09375
| 48
| 0.583984
| 0.391968
| 1
| 0
| 0
|
no
| 0.05
| 0
|
dnr after sadm
| 9
| 115
| 3.099609
| 105
| 12
| 38.39844
| 385.6875
| 2.699707
| 4.399414
| 1
| 131
| 7.449219
| 97
| 10
| 1,235
| null | 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
56.13397
|
female
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null |
under $11k
| 44
| 87,450
| 49,439.0625
| 50,099
| 38.333313
|
black
| 38.59375
| 95
| 0.067993
| 0.023998
| 7
| 0
| 0
|
yes
| 0.7
| 0.6
|
dnr after sadm
| 14
| 102
| 23.097656
| 105
| 33
| 36.29688
| 233.3125
| null | 0.799927
| 6.199219
| 133
| 7.379883
| 284
| 105
| 811
| null | 3
|
<2 mo. follow-up
| 3
| 14
| 1
|
34.34399
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 9
| 46,653
| null | null | 23.333328
|
black
| 29.398438
| 57
| 0.810913
| 0.748901
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 17
| 53
| 3.099609
| 115
| 10
| 36.39844
| 302.8125
| 1.399902
| 2.199707
| 0.699951
| 134
| 7.299805
| 81
| 27
| 3,160
| null | 0
|
no(M2 and SIP pres)
| 0
| 528
| 0
|
55.52597
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 92,466
| null | null | 26.25
|
white
| 31.398438
| 60
| 0.7229
| 0.638916
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 47
| null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 56
| 1
|
52.57999
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
| null | 9
| 13,753
| 8,494.375
| 9,086
| 12
|
black
| 15.798828
| 11
| 0.893921
| 0.855957
| 3
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 58
| 17.398438
| 115
| 16
| 35.79688
| 133.3125
| 0.899902
| 1.699951
| 4.899414
| 137
| 7.319336
| 72
| 60
| 88
| null | 1
|
no(M2 and SIP pres)
| 1
| 525
| 0
|
69.14996
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 3
| null | 0
| 12,983
| 8,177.3086
| 8,862
| 19
|
black
| 26.699219
| 28
| 0.753906
| 0.611938
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 6
| 125
| 17.898438
| 75
| 26
| 36.39844
| 196.65625
| null | null | 1
| 144
| 7.299805
| 512
| 18
| 3,945
| null | 0
|
no(M2 and SIP pres)
| 0
| 525
| 0
|
51.59497
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 26
| 43,406
| null | null | 40
|
black
| 78.1875
| 91
| 0
| 0
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 9
| 112
| 25
| 95
| 13
| 35.29688
| 356
| null | 14.398438
| 7.699219
| 134
| 7.419922
| 89
| 88
| 200
| null | 3
|
<2 mo. follow-up
| 3
| 9
| 1
|
65.33099
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| 18
|
>$50k
| 100
| 30,271
| 17,778.3438
| 17,836
| 19
|
white
| 65.796875
| 55
| 0
| 0
| 8
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 2
| 123
| 14.798828
| 135
| 40
| 39.09375
| 266.625
| 2.899902
| 1.099854
| 0.699951
| 140
| 7.429688
| 179
| 13
| 4,125
| null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
49.81198
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 17,471
| null | null | 50
|
black
| 51.09375
| 104
| 0.002
| 0
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 68
| 12.398438
| 115
| 9
| 38.89844
| 331.375
| null | 1.099854
| 5
| 144
| 7.489258
| 210
| 123
| 60
| null | null |
<2 mo. follow-up
| 3.373047
| 3
| 1
|
58.439
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 53,976
| 30,542.7031
| 32,550
| 32
|
white
| 26.796875
| 55
| 0.554932
| 0.441956
| 12
| 0
| 0
|
yes
| 0.3
| 0.1
|
dnr after sadm
| 1
| 107
| 10
| 80
| 28
| 36.29688
| null | 3.099609
| 0.5
| 0.599976
| 130
| null | 248
| 9
| 4,800
| null | null |
<2 mo. follow-up
| 2.542481
| 5
| 1
|
46.93799
|
male
| 1
| 6
|
Coma
|
Coma
| 0
| null | null | 41
| 80,331
| 45,993.3438
| 44,799
| 45
|
white
| 24.097656
| 32
| 0.584961
| 0.518921
| 9
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 5
| 124
| 15
| 125
| 30
| 36.19531
| 286.9375
| null | null | 1.699951
| 146
| 7.399414
| 114
| 52
| 875
| null | null |
<2 mo. follow-up
| 1.789063
| 6
| 1
|
29.782
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 165,685
| null | null | 33
|
black
| 25.097656
| 38
| 0.873901
| 0.828979
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 35
| 100
| 7.299805
| 64
| 32
| 36.59375
| 204.75
| null | null | 0.699951
| 139
| 7.299805
| 159
| 29
| 3,050
| null | null | null | 1.835205
| 522
| 0
|
71.42499
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 41
| 186,564
| 103,832.562
| 95,396
| 43.333313
|
white
| 16.796875
| 26
| 0.720947
| 0.634888
| 12
| 0
| 0
|
no
| null | null |
dnr after sadm
| 22
| 75
| 16.398438
| 112
| 16
| 36.29688
| null | null | 0.599976
| 0.699951
| 135
| null | 111
| 33
| null | null | 7
|
<2 mo. follow-up
| 7
| 23
| 1
|
55.87097
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,932
| 2,679.8769
| 3,388
| 7
|
white
| 30.796875
| 22
| 0.379944
| 0.090988
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 55
| 19.5
| 160
| 30
| 38
| 320
| 2.799805
| 0.799927
| 10
| 133
| 7.399414
| 78
| 89
| 200
| null | null |
<2 mo. follow-up
| 2.458984
| 4
| 1
|
32.43799
|
female
| 0
| 129
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$11-$25k
| 44
| 440,306
| null | null | 40.25
|
hispanic
| 36.09375
| 64
| 0.564941
| 0.453979
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 129
| 80
| 13.099609
| 128
| 24
| 36.09375
| 200
| null | null | 1.099854
| 135
| 7.129883
| 227
| 34
| 500
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 519
| 0
|
70.64496
|
female
| 0
| 108
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 171,148
| null | null | 26.5
|
white
| 26.597656
| 66
| 0.726929
| 0.642944
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 6
| 73
| 10.298828
| 75
| 20
| 38.29688
| 452.375
| null | null | 0.699951
| 134
| 7.469727
| 136
| 10
| null | 6
| 6
|
adl>=4 (>=5 if sur)
| 6
| 519
| 0
|
50.95398
|
male
| 1
| 41
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 0
| 180,519
| null | null | 40
|
white
| 29.898438
| 33
| 0.559937
| 0.44696
| 2
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 21
| 40
| 27.5
| 40
| 15
| 35.19531
| 268
| null | 2
| 1.299805
| 129
| 7.509766
| 106
| 20
| 455
| null | 0
|
<2 mo. follow-up
| 0
| 41
| 1
|
26.09698
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 9
| 25,295
| 16,307.4609
| 18,321
| 16
|
white
| 37.296875
| 69
| 0.713989
| 0.626953
| 1
| 1
| 0
|
no
| 1
| 1
|
dnr after sadm
| 4
| 105
| 9.699219
| 65
| 24
| 37
| 390.4375
| null | null | 1.299805
| 143
| 7.519531
| 107
| 22
| 2,150
| 2
| null |
SIP>=30
| 1.838867
| 517
| 0
|
67.26099
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 100
| null | null | null | 44
|
white
| 98
| 141
| 0
| 0
| 8
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 3
| 68
| 5.5
| 115
| 36
| 39.19531
| 82.84375
| 2.399902
| 11.099609
| 1.199951
| 155
| 7.449219
| 400
| 48
| 2,460
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
64.66498
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
$11-$25k
| 0
| 85,357
| 51,161.6875
| 54,012
| 22.5
|
other
| 27.296875
| 47
| 0.710938
| 0.623901
| 5
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 28
| 42
| 19.296875
| 65
| 33
| 33.69531
| 34
| 3.299805
| 32.398438
| 7.399414
| 147
| 7.279297
| 102
| 88
| 570
| null | null | null | 2.625
| 516
| 0
|
31.22499
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$25-$50k
| 44
| 27,355
| 16,787.5156
| 17,752
| 17
|
white
| 21.796875
| 27
| 0.791992
| 0.723999
| 10
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 4
| 83
| 8.599609
| 105
| 20
| 36.29688
| null | 3.599609
| 0.5
| 0.899902
| 134
| null | 121
| 14
| null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 330
| 1
|
50.97897
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 20,779
| 12,855.9375
| 12,840
| 14.333328
|
white
| 27.699219
| 37
| 0.814941
| 0.699951
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 14
| 137
| 13.199219
| 115
| 35
| 39.09375
| 319
| null | null | 0.599976
| 133
| 7.449219
| 160
| 17
| 2,065
| 0
| 2
|
<2 mo. follow-up
| 2
| 35
| 1
|
60.57797
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 8,274
| 5,460.8398
| 5,733
| 13
|
white
| 17.898438
| 25
| 0.891968
| 0.819946
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 102
| 7.799805
| 70
| 24
| 35.89844
| null | 3.299805
| 2.299805
| 1.199951
| 135
| null | 88
| 18
| 2,600
| 2
| 3
|
no(M2 and SIP pres)
| 3
| 516
| 0
|
87.29596
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 26
| 29,832
| null | null | 21.666656
|
white
| 30.296875
| 53
| 0.450989
| 0.33197
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 5
| 68
| 17.796875
| 55
| 6
| 36.09375
| 193.3125
| 3.099609
| 0.599976
| 1
| 136
| 7.299805
| 246
| 26
| 1,390
| null | 0
|
no(M2 and SIP pres)
| 0
| 515
| 0
|
78.70795
|
male
| 1
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 231,581
| null | null | 34.5
|
black
| 35.296875
| 67
| 0.375
| 0.255981
| 20
| 0
| 0
|
no
| null | null |
dnr after sadm
| 46
| 78
| 8.099609
| 75
| 6
| 36.29688
| 200
| null | 0.699951
| 0.699951
| 135
| 7.429688
| 81
| 15
| 2,930
| null | null |
<2 mo. follow-up
| 3.058106
| 49
| 1
|
41.94897
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 14,354
| 9,377.4453
| 9,969
| 11.5
|
hispanic
| 22.898438
| 25
| 0.639893
| 0.330994
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 12
| 105
| 7.199219
| 150
| 22
| 36.59375
| null | 2.899902
| 0.899902
| 0.799927
| 139
| null | 99
| 7
| 2,725
| 0
| 1
|
<2 mo. follow-up
| 1
| 30
| 1
|
64.94995
|
male
| 0
| 35
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
>$50k
| 0
| 100,447
| 59,049.2188
| 68,243
| 35
|
white
| 24.199219
| 33
| 0.815918
| 0.700928
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 19
| 63
| 6.799805
| 75
| 20
| 36.09375
| 644
| null | null | 1.299805
| 136
| 7.449219
| 63
| 19
| 4,700
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 337
| 1
|
85.20197
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 70,407
| 40,572.1562
| 42,464
| 42.5
|
other
| 53.898438
| 93
| 0.003
| 0
| 9
| 0
| 0
|
yes
| 0.1
| 0.05
|
dnr after sadm
| 3
| 73
| 4.199219
| 55
| 8
| 36
| 226.65625
| 2.299805
| 0.5
| 0.699951
| 141
| 7.379883
| 77
| 16
| 1,175
| null | 7
|
<2 mo. follow-up
| 7
| 11
| 1
|
33.13599
|
female
| 1
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 187,105
| 109,487.562
| 105,650
| 40.25
|
black
| 37.898438
| 64
| 0.699951
| 0.609985
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 1
| 111
| 7.599609
| 50
| 16
| 35.79688
| 210.1875
| null | null | 1
| 138
| 7.439453
| 78
| 14
| 700
| null | 2
|
<2 mo. follow-up
| 2
| 38
| 1
|
45.55798
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| 12
|
under $11k
| 100
| 24,542
| 14,387.2812
| 16,541
| 27
|
black
| 26
| 66
| 0.342957
| 0.269958
| 1
| 1
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 5
| 52
| 10.798828
| 105
| 26
| 40
| 210
| 3.399902
| 0.799927
| 1.699951
| 141
| 7.439453
| 100
| 66
| 1,210
| null | 1
|
<2 mo. follow-up
| 1
| 6
| 1
|
61.32199
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 12,236
| 5,965.6328
| 6,239
| 11
|
white
| 14.898438
| 5
| 0.753906
| 0.497986
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 4
| 58
| 23.597656
| 135
| 20
| 38.59375
| 98
| 2.099609
| 1
| 2
| 139
| 7.40918
| 206
| 73
| 1,030
| null | 0
|
no(M2 and SIP pres)
| 0
| 514
| 0
|
57.50598
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 37
| 99,616
| 56,783.5312
| 57,308
| 28.666656
|
white
| 27.597656
| 65
| 0.582886
| 0.472961
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 118
| 7.099609
| 125
| 9
| 38.29688
| 240
| null | null | 0.899902
| 140
| 7.589844
| 96
| 28
| 1,220
| null | 0
|
no(M2 and SIP pres)
| 0
| 512
| 0
|
72.68994
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 9
| 84,148
| null | null | 25.666656
|
white
| 22.199219
| 44
| 0.715942
| 0.628906
| 14
| 1
| 0
|
no
| null | null |
no dnr
| 17
| 63
| 14.099609
| 55
| 6
| 35.5
| 214.28125
| 2.5
| 2.599609
| 0.899902
| 143
| 7.369141
| 314
| 28
| 620
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 512
| 0
|
69.44299
|
female
| 0
| 97
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 11
|
$25-$50k
| 44
| 207,500
| null | null | 28.25
|
white
| 17.398438
| 49
| 0.773926
| 0.701904
| 1
| 1
| 1
|
no
| 0.5
| 0.5
|
no dnr
| 97
| 108
| 30.699219
| 135
| 16
| 37.09375
| 106.65625
| 2.399902
| 13.199219
| 5.399414
| 139
| 7.349609
| 99
| 142
| 431
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 511
| 0
|
27.29399
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| 43,502
| 27,744.9219
| 28,170
| 20
|
black
| 20.699219
| 17
| 0.848999
| 0.796997
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 122
| 15.699219
| 120
| 24
| 37.59375
| 193.3125
| null | 0.5
| 1.299805
| 136
| 7.489258
| 94
| 23
| 2,940
| null | 0
|
no(M2 and SIP pres)
| 0
| 510
| 0
|
54.75198
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$11-$25k
| 0
| 49,333
| 29,308.0625
| 32,056
| 26.333328
|
black
| 17.296875
| 12
| 0.895996
| 0.858887
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 108
| 12.5
| 75
| 30
| 35.5
| 146.65625
| null | null | 5
| 125
| 7.389648
| 351
| 74
| 1,350
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 510
| 0
|
67.27997
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 25,244
| null | null | 29
|
white
| 35.195313
| 38
| 0.35199
| 0.234985
| 1
| 0
| 1
|
no
| 0.6
| 0.6
|
no dnr
| 11
| 80
| 10.599609
| 80
| 20
| 36.59375
| 420
| null | 0.399963
| 0.5
| 137
| 7.389648
| 184
| 7
| 2,600
| null | null | null | 5.219727
| 509
| 0
|
75.90698
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 0
| 457,800
| null | null | 25.666656
|
white
| 20.097656
| 15
| 0.765991
| 0.691895
| 2
| 1
| 0
|
yes
| 1
| 0.95
|
no dnr
| 17
| 62
| 12.5
| 65
| 24
| 36.79688
| 260
| null | null | 1.199951
| 136
| 7.529297
| 211
| 23
| 2,470
| 7
| 1
|
no(M2 and SIP pres)
| 1
| 509
| 0
|
72.93097
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
|
$11-$25k
| 0
| 20,894
| 12,428.8359
| 10,096
| 21
|
white
| 20.796875
| 32
| 0.827881
| 0.718994
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 112
| 4.099609
| 105
| 32
| 36.29688
| 330.375
| null | null | 0.699951
| 136
| 7.359375
| 109
| 16
| 1,460
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 223
| 1
|
65.40997
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
>$50k
| 44
| 158,768
| 86,304.1875
| 96,859
| 47.666657
|
white
| 38.59375
| 54
| 0.162994
| 0.080994
| 14
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 16
| 118
| 6.799805
| 65
| 26
| 36.89844
| 112.23438
| null | 0.699951
| 10.798828
| 134
| 7.389648
| 81
| 45
| 1,400
| null | 4
|
<2 mo. follow-up
| 4
| 18
| 1
|
88.487
|
female
| 1
| 9
|
Coma
|
Coma
| 1
| 15
|
under $11k
| 100
| 6,748
| 5,192.2344
| 5,946
| 8
|
white
| 19.597656
| 24
| 0.116989
| 0.071991
| 1
| 0
| 0
|
no
| 0.05
| 0
|
dnr after sadm
| 1
| 48
| 4.299805
| 65
| 24
| 38.09375
| 57
| null | 0.5
| 2.899902
| 140
| 7.30957
| 149
| 30
| 140
| null | 5
|
<2 mo. follow-up
| 5
| 9
| 1
|
59.75598
|
male
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 0
| 287,011
| null | null | 48.75
|
white
| 32.796875
| 52
| 0.635986
| 0.533936
| 3
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 59
| 100
| 10.898438
| 104
| 20
| 37
| null | 3.099609
| 1
| 0.899902
| 133
| null | 102
| 8
| null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 509
| 0
|
86.50494
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$11-$25k
| 0
| 113,600
| 65,823.9375
| 70,361
| 34.75
|
white
| 29
| 37
| 0.61499
| 0.509888
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 35
| 46
| 10.099609
| 135
| 38
| 37.79688
| 231.40625
| null | null | 0.5
| 136
| 7.519531
| 103
| 4
| 5,095
| null | null |
adl>=4 (>=5 if sur)
| 2.561523
| 150
| 1
|
67.87396
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 17,619
| 10,628.3594
| 11,509
| 13
|
white
| 12.898438
| 30
| 0.774902
| 0.531982
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 62
| 19.5
| 135
| 40
| 35.59375
| 145
| 2.699707
| 7.599609
| 1.799805
| 135
| 7.479492
| 238
| 43
| 711
| 4
| 5
|
SIP>=30
| 5
| 172
| 1
|
47.10999
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 95,153
| 55,380.75
| 59,054
| 20.5
|
white
| 21.796875
| 41
| 0.859985
| 0.81189
| 4
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 27
| 58
| 16.699219
| 125
| 47
| 36.19531
| 82.84375
| null | null | 0.899902
| 137
| 7.389648
| 150
| 13
| 694
| null | 0
|
no(M2 and SIP pres)
| 0
| 507
| 0
|
49.79099
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 5,730
| 4,198.6523
| 4,977
| 12
|
white
| 19
| 34
| 0.852905
| 0.756958
| 1
| 1
| 0
|
no
| 0.5
| 0.35
|
no dnr
| 6
| 112
| 8.398438
| 100
| 27
| 38.19531
| 226.65625
| null | null | 0.699951
| 148
| 7.429688
| 118
| 5
| 1,290
| null | 7
|
no(M2 and SIP pres)
| 7
| 508
| 0
|
79.00299
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 22,539
| null | null | 24
|
black
| 15.298828
| 30
| 0.869995
| 0.784912
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 52
| 0.099991
| 155
| 31
| 38.19531
| 233.3125
| null | 14.898438
| 5.299805
| 141
| 7.339844
| 271
| 98
| 22
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 374
| 1
|
68.42999
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$25-$50k
| 44
| 664,520
| 39,274.75
| 39,782
| 46
|
white
| 32.695313
| 59
| 0.329956
| 0.214996
| 1
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 3
| 52
| 10.099609
| 130
| 32
| 39.79688
| 127.5
| null | 0.899902
| 1.099854
| 131
| 7.5
| 135
| 23
| 3,115
| null | 1
|
<2 mo. follow-up
| 1
| 13
| 1
|
84.69299
|
female
| 1
| 9
|
Coma
|
Coma
| 0
| 8
|
under $11k
| 100
| 15,003
| 9,909.3594
| 9,405
| 17.5
|
white
| 15.898438
| 13
| 0.240997
| 0.175995
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 67
| 0.599976
| 125
| 32
| 39
| 420
| 2.099609
| 4.899414
| 3.399902
| 138
| 7.329102
| 193
| 23
| 290
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
65.61798
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 9,071
| 6,422.4492
| 6,518
| 11.5
|
white
| 22.199219
| 18
| 0.733887
| 0.463989
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 9
| 133
| 23
| 115
| 13
| 36.89844
| 304
| 2.099609
| 0.899902
| 6.699219
| 131
| 7.369141
| 102
| 67
| 1,595
| null | 2
|
no(M2 and SIP pres)
| 2
| 433
| 1
|
25.45099
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
| null | 44
| 118,800
| 75,492
| 72,145
| 34
|
white
| 39.09375
| 71
| 0.527954
| 0.411987
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 31
| 55
| 10.599609
| 125
| 9
| 36.69531
| 297.125
| null | 0.899902
| 5.5
| 133
| 7.30957
| 75
| 72
| 0
| null | null |
no(M2 and SIP pres)
| 2.327148
| 504
| 0
|
70.81195
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 13,868
| 8,521.0938
| 8,790
| 6
|
white
| 14
| 14
| 0.844971
| 0.657959
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 103
| 12
| 60
| 16
| 37.5
| 255
| 2.899902
| 0.599976
| 1
| 140
| 7.40918
| 204
| 2
| 4,960
| 1
| 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
51.02298
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
under $11k
| 0
| 22,219
| null | null | 25
|
black
| 24.597656
| 28
| 0.815918
| 0.754883
| 4
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 6
| 97
| 11.599609
| 60
| 20
| 36.69531
| 101.65625
| 4.099609
| 0.699951
| 6.699219
| 134
| 7.329102
| 92
| 46
| 3,205
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 501
| 0
|
62.702
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 44
| 96,689
| 58,644
| 53,797
| 33.25
|
white
| 16.796875
| 36
| 0.806885
| 0.741943
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
no dnr
| 26
| 0
| 9.199219
| 0
| 0
| 36
| 76
| 2.099609
| 0.699951
| 1.5
| 138
| 7.279297
| 292
| 11
| 1,640
| null | 0
|
no(M2 and SIP pres)
| 0
| 501
| 0
|
71.49597
|
male
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 4
|
under $11k
| 9
| 87,170
| 47,979.6875
| 54,320
| 32.666657
|
white
| 45.59375
| 76
| 0.023998
| 0.006
| 4
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 22
| 0
| 9.398438
| 0
| 0
| 38.19531
| 236.65625
| null | null | 0.799927
| 140
| 7.459961
| 142
| 14
| 2,300
| null | 4
|
<2 mo. follow-up
| 4
| 23
| 1
|
66.98199
|
male
| 0
| 95
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 41
| 373,539
| null | null | 36.5
|
white
| 28.5
| 32
| 0.503906
| 0.302979
| 5
| 1
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 45
| 41
| 13.5
| 0
| 26
| 38.19531
| 137
| null | 2.599609
| 2.599609
| 137
| 6.929688
| 543
| 40
| 140
| null | 6
|
Coma or Intub
| 6
| 498
| 0
|
64.80499
|
male
| 0
| 10
|
Coma
|
Coma
| 1
| null | null | 100
| 25,298
| 15,532.8359
| 16,117
| 25.5
|
white
| 24.296875
| 33
| 0.200989
| 0.140991
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 10
| 65
| 0.099991
| 75
| 25
| 35.59375
| 271.375
| 2.299805
| 1.299805
| 1
| 139
| 7.429688
| 178
| 28
| 2,040
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 399
| 1
|
47.27399
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 44
| 42,132
| 25,258.0781
| 27,767
| 22
|
white
| 23.199219
| 28
| 0.728882
| 0.644897
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 167
| 11.699219
| 170
| 24
| 39.59375
| 254.28125
| null | null | 0.5
| 135
| 7.459961
| 136
| 16
| 3,940
| null | 0
|
no(M2 and SIP pres)
| 0
| 177
| 1
|
58.87698
|
male
| 1
| 26
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 60,235
| null | null | 21.5
|
white
| 21.199219
| 23
| 0.866943
| 0.779907
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 26
| 115
| 8.099609
| 140
| 10
| 39.09375
| 168.5625
| 3.199707
| 3.099609
| 1.5
| 135
| 7.369141
| 110
| 18
| 2,750
| 5
| 5
|
<2 mo. follow-up
| 5
| 26
| 1
|
62.40097
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 21,075
| 12,266.7188
| 12,473
| 33
|
white
| 30.898438
| 48
| 0.454956
| 0.335999
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.3
|
dnr after sadm
| 4
| 72
| 20.796875
| 75
| 9
| 36.79688
| 277.125
| null | null | 1.399902
| 139
| 7.419922
| 199
| 71
| 1,190
| null | null |
<2 mo. follow-up
| 2.602539
| 4
| 1
|
60.84097
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
$11-$25k
| 9
| 80,127
| null | null | 27
|
white
| 28.5
| 55
| 0.689941
| 0.5979
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 28
| 107
| 12.798828
| 88
| 28
| 36
| 135
| null | null | 0.799927
| 125
| 7.379883
| 149
| 19
| 1,700
| null | 6
| null | 6
| 494
| 0
|
58.97598
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 41
| 30,892
| 18,894.8906
| 18,901
| 35
|
white
| 24.5
| 44
| 0.679932
| 0.585938
| 2
| 1
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 7
| 112
| 55.898438
| 135
| 37
| 38.79688
| 77
| 1.5
| 3.099609
| 0.599976
| 136
| 7.379883
| 104
| 9
| 1,420
| null | null |
<2 mo. follow-up
| 3.194336
| 8
| 1
|
81.08698
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 20,828
| null | null | 27
|
white
| 26
| 42
| 0.706909
| 0.546997
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 125
| 12.599609
| 155
| 40
| 39.79688
| 316
| 2.299805
| 0.899902
| 0.599976
| 145
| 7.399414
| 229
| 31
| 1,300
| null | null |
<2 mo. follow-up
| 2.28418
| 4
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.